Commercially Available Nanoparticles for Cancer Treatment
Published on 18 Dec, 2015
Since their advent in the late 1960s, several nanoparticle-based drugs are being clinically used in innovative therapeutic approaches with notable success.
Several nano formulations of liposomal and PEG-conjugated liposomal, polymeric micelles anticancer drugs have been approved, with some already approved for clinical use and others undergoing phase II and III clinical trials.
Commercially Available Nanoparticle-based Cancer Treatment
For more information about the use of Nanoparticles and their applications in cancer treatment, check out our report on Nanoparticle Drug Delivery Systems for Cancer Treatment.